Cumberland Pharmaceuticals Inc (CPIX) — Strategic Asset Allocation Index
Cumberland Pharmaceuticals Inc (CPIX) has a Strategic Asset Allocation Index of 18.0% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $3.84 Million) total $3.84 Million, measured against net assets of $21.30 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Cumberland Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Cumberland Pharmaceuticals Inc Strategic Asset Allocation Index (2007–2025)
This chart shows how Cumberland Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2007 to 2025. As of March 2026, the index stands at 18.0%, representing strategic assets of $3.84 Million against net assets of $21.30 Million USD. For live market cap and overall valuation, see CPIX stock market capitalisation.
Annual Strategic Asset Allocation Index for Cumberland Pharmaceuticals Inc (2007–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Cumberland Pharmaceuticals Inc from 2007 to 2025, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Cumberland Pharmaceuticals Inc shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 16.2% | $3.99 Million | $- | $3.99 Million | $24.54 Million | ▲ +16.2 pp |
| 2024 | 0.0% | $0.00 | $- | $0.00 | $22.55 Million | ▼ -15.3 pp |
| 2022 | 15.3% | $5.50 Million | $5.50 Million | $- | $35.97 Million | ▲ +11.9 pp |
| 2021 | 3.4% | $1.47 Million | $1.47 Million | $- | $42.60 Million | ▼ -22.7 pp |
| 2020 | 26.1% | $12.23 Million | $12.23 Million | $- | $46.87 Million | ▼ -5.8 pp |
| 2019 | 31.9% | $16.30 Million | $16.30 Million | $- | $51.09 Million | ▲ +30.5 pp |
| 2018 | 1.4% | $771.21K | $771.21K | $- | $55.57 Million | ▲ +0.6 pp |
| 2017 | 0.8% | $528.88K | $528.88K | $- | $63.92 Million | ▲ +0.2 pp |
| 2016 | 0.6% | $464.45K | $464.45K | $- | $73.12 Million | ▼ -0.1 pp |
| 2015 | 0.7% | $536.45K | $536.45K | $- | $76.82 Million | ▼ -0.1 pp |
| 2014 | 0.8% | $651.00K | $651.00K | $- | $80.75 Million | ▼ -0.3 pp |
| 2013 | 1.1% | $880.65K | $880.65K | $- | $79.29 Million | ▼ -0.3 pp |
| 2012 | 1.4% | $1.19 Million | $1.19 Million | $- | $85.57 Million | ▲ +0.0 pp |
| 2011 | 1.4% | $1.12 Million | $1.12 Million | $- | $82.84 Million | ▼ -0.2 pp |
| 2010 | 1.6% | $1.22 Million | $1.22 Million | $- | $77.72 Million | ▲ +0.3 pp |
| 2009 | 1.3% | $918.00K | $918.00K | $- | $72.22 Million | ▼ -1.2 pp |
| 2008 | 2.5% | $432.00K | $432.00K | $- | $17.55 Million | ▼ -0.3 pp |
| 2007 | 2.7% | $460.00K | $460.00K | $- | $16.75 Million | — |